Abbott (ABT) Reports In-Line Q4 EPS; Guides FY17 EPS In-Line
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $103.36 -1.78%
Revenue Growth %: +14.2%
Financial Fact:
Net foreign exchange loss (gain): 9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +14.2%
Financial Fact:
Net foreign exchange loss (gain): 9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q4 EPS of $0.65, in-line with the analyst estimate of $0.65. Revenue for the quarter came in at $5.33 billion versus the consensus estimate of $5.38 billion.
GUIDANCE:
Abbott sees FY2017 EPS of $2.40-$2.50, versus the consensus of $2.45.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Adobe Systems (ADBE) Tops Q3 EPS by 6c, Offers Guidance
- Oracle raises full year profit guidance, stock rises after hours
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
